Christopher W. Krueger, Chief Business Officer at Ventyx Biosciences, Inc. (VTYX), sold 29,006 shares at $29.93 ($869K) on 2023-10-03, disclosed to the SEC on 2023-10-04.
Open-market sale of $869k VTYX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.93 | 14,006 | $419K | 48.2% |
| 2 | $29.93 | 14,006 | $419K | 48.2% |
| 3 | $30.70 | 994 | $31K | 3.5% |
| Total | $29.96 avg | 29,006 | $869K | 100% |
| Filing → |
| VTYX | SELL | 2023-09-07 | $977K | — | Filing → |
| VTYX | SELL | 2023-08-04 | $1.1M | — | Filing → |
| VTYX | SELL | 2023-07-05 | $1.1M | — | Filing → |